4.8 Review

FXR: a metabolic regulator and cell protector

Journal

CELL RESEARCH
Volume 18, Issue 11, Pages 1087-1095

Publisher

INST BIOCHEMISTRY & CELL BIOLOGY
DOI: 10.1038/cr.2008.289

Keywords

FXR; bile acid; metabolism; liver regeneration; hepatocarcinogenesis

Categories

Funding

  1. Sidney Kimmel Foundation for Cancer Research
  2. Margaret E Early Medical Research Trust
  3. STOP CANCER Foundation, USA

Ask authors/readers for more resources

Farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily of ligand-activated transcription factors. As a metabolic regulator, FXR plays key roles in bile acid, cholesterol, lipid, and glucose metabolism. Therefore, FXR is a potential drug target for a number of metabolic disorders, especially those related to the metabolic syndrome. More recently, our group and others have extended the functions of FXR to more than metabolic regulation, which include anti-bacterial growth in intestine, liver regeneration, and hepatocarcinogenesis. These new findings suggest that FXR has much broader roles than previously thought, and also highlight FXR as a drug target for multiple diseases. This review summarizes the basic information of FXR but focuses on its new functions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available